Take off with Allogene Therapeutics Inc (ALLO): Get ready for trading

With 5.77 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.4 million shares. The 52-week range on ALLO shows that it touched its highest point at $3.78 and its lowest point at $1.23 during that stretch. It currently has a 1-year price target of $9.18. Beta for the stock currently stands at 0.42.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ALLO was down-trending over the past week, with a drop of -16.88%, but this was down by -11.11% over a month. Three-month performance dropped to -20.99% while six-month performance fell -49.90%. The stock lost -56.90% in the past year, while it has lost -39.91% so far this year. A look at the trailing 12-month EPS for ALLO yields -1.34 with Next year EPS estimates of -1.27. For the next quarter, that number is -0.29. This implies an EPS growth rate of 8.21% for this year and -4.55% for next year. EPS is expected to decline by -0.69% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 6.26%.

Float and Shares Shorts:

At present, 212.21 million ALLO shares are outstanding with a float of 143.20 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ALLO since 6 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.27375 being high and -$1.43052 being low. For ALLO, this leads to a yearly average estimate of -$1.33254.